Proteases in Medicine: Unlocking Therapeutic and Clinical Potential of Nature’s Catalysts

Proteases represent a rather heterogeneous group of enzymes that accomplish hydrolysis in peptide bond, and are central in a wide range of biological mechanisms, be-coming a major focus of medical research. Proteases can now be traditionally known as involved in the process of the protein degradation but today they have been known to regulate many physiological activities, including proliferation, apoptosis, immune amendment, and tissue reshaping. Protease expression or activity aberrations, particularly those that occur during the development and progression of many diseases including cancer, cardiovascular diseases, inflammatory diseases, and neurodegenerative syndromes are closely correlated to the levels of disease pathogenesis. Consequently, these enzymes have received a high level of interest both as biomarkers of early disease diagnoses as well as treatment targets. Particular attention is paid to natural and artificial proteases in the current clinical practice or under development as therapeutic agents in several treatment modes, such as thrombolytic and wound debridement, cancer therapy, and drug delivery. Integrating the existing research, the paper includes the most important discoveries and areas that still need to be under-stood, making the research comprehensive and resting on the fact that proteases are inherently the catalytic tools of nature that have the power to change the way things are used in the medical world today.